Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-29 @ 10:16 AM
Study NCT ID:
NCT06874257
Status:
RECRUITING
Last Update Posted:
2025-03-13
First Post:
2024-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TALETE-2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None